• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以植物为主的健康饮食作为代谢功能障碍相关脂肪性肝病治疗中替代饮食方法的一种选择。

A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.

机构信息

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Gastroenterology Unit, Città della Salute e della Scienza-Molinette Hospital, 10126 Turin, Italy.

出版信息

Nutrients. 2024 Jun 26;16(13):2027. doi: 10.3390/nu16132027.

DOI:10.3390/nu16132027
PMID:38999775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11243448/
Abstract

Plant-based diets (PBDs) are gaining attention as a sustainable and health-conscious alternative for managing various chronic conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD). In the absence of pharmacological treatments, exploring the potential of lifestyle modifications to improve biochemical and pathological outcomes becomes crucial. The adoption of PBDs has demonstrated beneficial effects such as weight control, increased metabolic health and improved coexisting diseases. Nonetheless, challenges persist, including adherence difficulties, ensuring nutritional adequacy, and addressing potential deficiencies. The aim of this review is to provide a comprehensive overview of the impact of PBDs on MASLD, emphasizing the need for tailored dietary interventions with professional support to optimize their effectiveness in preventing and treating metabolic diseases.

摘要

植物性饮食(PBD)作为一种可持续且注重健康的选择,正受到越来越多的关注,可用于治疗各种慢性疾病,包括代谢功能障碍相关脂肪性肝病(MASLD)。在缺乏药物治疗的情况下,探索生活方式改变的潜力以改善生化和病理结果变得至关重要。采用 PBD 已显示出有益的效果,如体重控制、增加代谢健康和改善并存疾病。然而,仍存在一些挑战,包括坚持困难、确保营养充足以及解决潜在的营养缺乏问题。本综述的目的是全面概述 PBD 对 MASLD 的影响,强调需要有专业支持的个性化饮食干预措施,以优化其在预防和治疗代谢性疾病方面的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f1e/11243448/c41834675e35/nutrients-16-02027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f1e/11243448/c41834675e35/nutrients-16-02027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f1e/11243448/c41834675e35/nutrients-16-02027-g001.jpg

相似文献

1
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.以植物为主的健康饮食作为代谢功能障碍相关脂肪性肝病治疗中替代饮食方法的一种选择。
Nutrients. 2024 Jun 26;16(13):2027. doi: 10.3390/nu16132027.
2
Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review.与素食饮食和代谢功能障碍相关的脂肪性肝病的证据:系统评价方案。
BMJ Open. 2024 Apr 10;14(4):e079750. doi: 10.1136/bmjopen-2023-079750.
3
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?饮食、运动和补充剂:在儿童代谢功能障碍相关脂肪性肝病的管理中,它们各自扮演什么角色?
Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22.
4
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial.炎症标志物作为代谢功能障碍相关脂肪性肝病的诊断和精准营养工具:来自肥胖相关性脂肪肝试验的结果。
Clin Nutr. 2024 Jul;43(7):1770-1781. doi: 10.1016/j.clnu.2024.05.042. Epub 2024 May 31.
5
Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病患者的心血管风险管理。
Eur J Intern Med. 2024 Apr;122:28-34. doi: 10.1016/j.ejim.2023.11.012. Epub 2023 Nov 25.
6
The Associations between Healthy Eating Patterns and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case-Control Study.健康饮食习惯与代谢相关脂肪性肝病风险的关联:病例对照研究。
Nutrients. 2024 Jun 19;16(12):1956. doi: 10.3390/nu16121956.
7
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.代谢相关脂肪性肝病:术语演变、诊断前沿和治疗视野的探索——述评。
World J Gastroenterol. 2024 May 14;30(18):2387-2390. doi: 10.3748/wjg.v30.i18.2387.
8
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.超重和肥胖代谢功能障碍相关脂肪性肝病患者极低卡路里生酮饮食 8 周前后肝脂肪变性和纤维化的性别差异。
Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408.
9
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum.代谢相关脂肪性肝病-肝硬化谱系的发病机制与可能的治疗方法之间的关系
Int J Mol Sci. 2024 Apr 16;25(8):4397. doi: 10.3390/ijms25084397.
10
Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.代谢功能障碍相关脂肪性肝病:从发病机制到当前治疗选择。
Int J Mol Sci. 2024 May 22;25(11):5640. doi: 10.3390/ijms25115640.

引用本文的文献

1
Dietary Strategies in the Prevention of MASLD: A Comprehensive Review of Dietary Patterns Against Fatty Liver.预防代谢相关脂肪性肝病的饮食策略:针对脂肪肝的饮食模式综合综述
Metabolites. 2025 Aug 4;15(8):528. doi: 10.3390/metabo15080528.
2
Lights and Shadows of a Vegetarian Diet in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者素食的利弊
Nutrients. 2025 May 12;17(10):1644. doi: 10.3390/nu17101644.
3
Milpa Diet for MASLD in Mesoamerican Populations: Feasibility, Advantages, and Future Perspectives.

本文引用的文献

1
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南:代谢功能障碍相关脂肪性肝病(MASLD)的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
2
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease.肝选择性胰岛素抵抗:胰岛素信号与代谢功能障碍相关脂肪性肝病的交汇点。
Cell Metab. 2024 May 7;36(5):947-968. doi: 10.1016/j.cmet.2024.04.006.
3
Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review.
中美洲人群中用于非酒精性脂肪性肝炎相关脂肪性肝病的米尔帕饮食:可行性、优势及未来展望
Life (Basel). 2025 May 19;15(5):812. doi: 10.3390/life15050812.
4
Sex-Specific Biochemical and Histopathological Effects of Chronic Meat-Based vs. Plant-Based Burger Consumption in a Rodent Model.基于肉类与植物性汉堡的长期消费对啮齿动物模型的性别特异性生化和组织病理学影响
Foods. 2025 Mar 5;14(5):888. doi: 10.3390/foods14050888.
5
Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.遵循行星健康饮食指数与代谢功能障碍相关脂肪性肝病:一项横断面研究。
Front Nutr. 2025 Feb 20;12:1534604. doi: 10.3389/fnut.2025.1534604. eCollection 2025.
6
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease.从肠道菌群失调到肝脏炎症:关于脂肪性肝病中饮食-微生物群-肝脏轴的叙述性综述
Microorganisms. 2025 Jan 23;13(2):241. doi: 10.3390/microorganisms13020241.
7
YouTube as a Source of Information for Dietary Guidance and Advisory Content in the Management of Non-Alcoholic Fatty Liver Disease.YouTube作为非酒精性脂肪性肝病管理中饮食指导和咨询内容的信息来源
Healthcare (Basel). 2025 Feb 7;13(4):351. doi: 10.3390/healthcare13040351.
8
Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management.对抗肥胖相关肝病的营养策略:医学营养治疗在代谢功能障碍相关脂肪性肝病(MASLD)管理中的作用
Curr Obes Rep. 2025 Jan 11;14(1):7. doi: 10.1007/s13679-024-00597-6.
9
Effects of plant-based diet on metabolic parameters, liver and kidney steatosis: a prospective interventional open-label study.植物性饮食对代谢参数、肝脏和肾脏脂肪变性的影响:一项前瞻性干预性开放标签研究。
Br J Nutr. 2025 Jan 10;133(3):1-10. doi: 10.1017/S0007114525000017.
10
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.代谢相关脂肪性肝病:氧化应激、炎症、线粒体功能障碍的影响及多酚的作用
Pharmaceuticals (Basel). 2024 Oct 10;17(10):1354. doi: 10.3390/ph17101354.
与素食饮食和代谢功能障碍相关的脂肪性肝病的证据:系统评价方案。
BMJ Open. 2024 Apr 10;14(4):e079750. doi: 10.1136/bmjopen-2023-079750.
4
Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks.饮酒对肥胖和脂肪性肝病的影响:对代谢途径和心血管风险的共同影响。
Curr Obes Rep. 2024 Sep;13(3):461-474. doi: 10.1007/s13679-024-00560-5. Epub 2024 Mar 23.
5
Plant-Based Diets and Metabolic Syndrome Components: The Questions That Still Need to Be Answered-A Narrative Review.植物性饮食与代谢综合征成分:仍待解答的问题——一项叙述性综述。
Nutrients. 2024 Jan 4;16(1):165. doi: 10.3390/nu16010165.
6
A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease.一种用于非酒精性脂肪性肝病管理的营养基因精准方法。
Clin Nutr. 2023 Nov;42(11):2181-2187. doi: 10.1016/j.clnu.2023.09.022. Epub 2023 Sep 25.
7
Plant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease.植物性饮食、遗传易感性与非酒精性脂肪性肝病风险。
BMC Med. 2023 Sep 12;21(1):351. doi: 10.1186/s12916-023-03028-w.
8
Scoping review of the association of plant-based diet quality with health outcomes.植物性饮食质量与健康结果关联的范围综述
Front Nutr. 2023 Aug 10;10:1211535. doi: 10.3389/fnut.2023.1211535. eCollection 2023.
9
Association between plant-based dietary pattern and biological aging trajectory in a large prospective cohort.基于植物的饮食模式与大型前瞻性队列中生物老化轨迹的关系。
BMC Med. 2023 Aug 17;21(1):310. doi: 10.1186/s12916-023-02974-9.
10
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.